avrg: GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
OLIG3
|
ENSG00000177468.7 | OLIG3 |
NEUROD2
|
ENSG00000171532.5 | NEUROD2 |
NEUROG2
|
ENSG00000178403.4 | NEUROG2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
NEUROG2 | hg38_v1_chr4_-_112516176_112516181 | 0.21 | 1.6e-03 | Click! |
NEUROD2 | hg38_v1_chr17_-_39607876_39607966 | 0.15 | 2.4e-02 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.5 | 10.5 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
3.2 | 12.6 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
2.3 | 6.8 | GO:0007525 | somatic muscle development(GO:0007525) |
2.2 | 6.5 | GO:0052047 | interaction with other organism via secreted substance involved in symbiotic interaction(GO:0052047) |
2.0 | 25.8 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
1.5 | 6.0 | GO:2000612 | thyroid-stimulating hormone secretion(GO:0070460) regulation of thyroid-stimulating hormone secretion(GO:2000612) |
1.0 | 3.0 | GO:0060739 | mesenchymal-epithelial cell signaling involved in prostate gland development(GO:0060739) |
0.9 | 2.8 | GO:0042137 | sequestering of neurotransmitter(GO:0042137) |
0.9 | 6.3 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.8 | 2.5 | GO:0072277 | metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
0.7 | 0.7 | GO:0060701 | negative regulation of ribonuclease activity(GO:0060701) negative regulation of endoribonuclease activity(GO:0060702) |
0.7 | 2.2 | GO:1901876 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
0.7 | 2.9 | GO:0055011 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
0.7 | 6.8 | GO:0036309 | protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
0.7 | 2.7 | GO:0097325 | melanocyte proliferation(GO:0097325) |
0.7 | 3.3 | GO:0003350 | pulmonary myocardium development(GO:0003350) |
0.6 | 4.2 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
0.6 | 3.0 | GO:1904073 | regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
0.6 | 1.8 | GO:0016487 | sesquiterpenoid metabolic process(GO:0006714) sesquiterpenoid catabolic process(GO:0016107) farnesol metabolic process(GO:0016487) farnesol catabolic process(GO:0016488) regulation of testosterone biosynthetic process(GO:2000224) |
0.6 | 3.4 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.5 | 1.6 | GO:0002086 | diaphragm contraction(GO:0002086) |
0.5 | 15.6 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.5 | 4.6 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
0.5 | 2.0 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.5 | 2.0 | GO:0006272 | leading strand elongation(GO:0006272) |
0.5 | 4.4 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.5 | 2.4 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.5 | 4.2 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.5 | 1.4 | GO:0007057 | spindle assembly involved in female meiosis I(GO:0007057) |
0.5 | 1.4 | GO:0072233 | thick ascending limb development(GO:0072023) metanephric thick ascending limb development(GO:0072233) |
0.5 | 1.8 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.4 | 2.7 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.4 | 7.1 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
0.4 | 1.3 | GO:1900920 | regulation of amino acid uptake involved in synaptic transmission(GO:0051941) regulation of glutamate uptake involved in transmission of nerve impulse(GO:0051946) regulation of L-glutamate import(GO:1900920) |
0.4 | 3.5 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.4 | 0.9 | GO:0072717 | cellular response to actinomycin D(GO:0072717) |
0.4 | 2.2 | GO:0093001 | glycolysis from storage polysaccharide through glucose-1-phosphate(GO:0093001) |
0.4 | 1.2 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.4 | 1.6 | GO:1900827 | maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
0.4 | 4.4 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.4 | 1.6 | GO:0036116 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
0.4 | 4.8 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.4 | 1.5 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.4 | 2.3 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.4 | 2.7 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.4 | 1.2 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
0.4 | 1.8 | GO:0034334 | adherens junction maintenance(GO:0034334) |
0.4 | 7.9 | GO:0052695 | cellular glucuronidation(GO:0052695) |
0.4 | 3.9 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.3 | 1.3 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.3 | 4.0 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.3 | 1.5 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
0.3 | 3.7 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
0.3 | 1.8 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) meiotic sister chromatid cohesion(GO:0051177) |
0.3 | 0.9 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.3 | 1.7 | GO:0035617 | stress granule disassembly(GO:0035617) |
0.3 | 0.8 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
0.3 | 1.1 | GO:0036215 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) diapedesis(GO:0050904) |
0.3 | 1.6 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.3 | 1.9 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
0.3 | 3.7 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) pyramidal neuron development(GO:0021860) |
0.3 | 2.3 | GO:0007068 | negative regulation of transcription during mitosis(GO:0007068) negative regulation of transcription from RNA polymerase II promoter during mitosis(GO:0007070) |
0.3 | 1.5 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.3 | 0.8 | GO:0046504 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.3 | 2.8 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.3 | 0.8 | GO:1901805 | beta-glucoside metabolic process(GO:1901804) beta-glucoside catabolic process(GO:1901805) positive regulation of neuronal action potential(GO:1904457) |
0.2 | 0.7 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
0.2 | 1.9 | GO:0006561 | proline biosynthetic process(GO:0006561) L-proline biosynthetic process(GO:0055129) |
0.2 | 1.0 | GO:0033076 | isoquinoline alkaloid metabolic process(GO:0033076) |
0.2 | 1.0 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
0.2 | 1.6 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.2 | 2.4 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.2 | 4.2 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.2 | 1.2 | GO:0061107 | seminal vesicle development(GO:0061107) |
0.2 | 1.4 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
0.2 | 0.9 | GO:0001519 | peptide amidation(GO:0001519) protein amidation(GO:0018032) peptide modification(GO:0031179) |
0.2 | 1.6 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.2 | 0.9 | GO:0050957 | equilibrioception(GO:0050957) |
0.2 | 2.0 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.2 | 3.8 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.2 | 0.7 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.2 | 2.4 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.2 | 1.3 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.2 | 0.9 | GO:0010585 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
0.2 | 1.5 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.2 | 1.0 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.2 | 0.8 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.2 | 0.6 | GO:2000234 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
0.2 | 1.2 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.2 | 1.6 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.2 | 0.8 | GO:0018106 | peptidyl-histidine phosphorylation(GO:0018106) |
0.2 | 9.8 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
0.2 | 1.7 | GO:0019375 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.2 | 0.7 | GO:0043324 | eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
0.2 | 1.1 | GO:0036018 | cellular response to erythropoietin(GO:0036018) |
0.2 | 0.9 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.2 | 0.5 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.2 | 6.6 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.2 | 0.5 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.2 | 0.5 | GO:0015888 | thiamine transport(GO:0015888) thiamine transmembrane transport(GO:0071934) |
0.2 | 2.6 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.2 | 2.8 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.2 | 9.1 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.2 | 0.5 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.2 | 0.8 | GO:0042374 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.2 | 0.6 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.2 | 4.2 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.2 | 0.5 | GO:0018874 | benzoate metabolic process(GO:0018874) butyrate metabolic process(GO:0019605) |
0.2 | 1.4 | GO:2000582 | regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
0.1 | 2.8 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.1 | 1.2 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.1 | 3.4 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.1 | 0.5 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.1 | 0.9 | GO:0070560 | protein secretion by platelet(GO:0070560) |
0.1 | 7.4 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.1 | 4.5 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.1 | 0.9 | GO:1903895 | negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
0.1 | 0.6 | GO:1900225 | regulation of NLRP3 inflammasome complex assembly(GO:1900225) |
0.1 | 0.5 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
0.1 | 0.6 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.1 | 0.2 | GO:0046136 | positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
0.1 | 0.6 | GO:0015891 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
0.1 | 0.4 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.1 | 1.5 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.1 | 2.1 | GO:0032060 | bleb assembly(GO:0032060) |
0.1 | 0.9 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.1 | 1.3 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.1 | 0.3 | GO:0021592 | midbrain-hindbrain boundary morphogenesis(GO:0021555) fourth ventricle development(GO:0021592) third ventricle development(GO:0021678) |
0.1 | 0.7 | GO:0070171 | negative regulation of tooth mineralization(GO:0070171) |
0.1 | 0.7 | GO:0043696 | dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
0.1 | 1.6 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.1 | 0.9 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
0.1 | 1.8 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
0.1 | 1.3 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.1 | 2.4 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.1 | 1.9 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.1 | 1.0 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.1 | 2.2 | GO:0006221 | pyrimidine nucleotide biosynthetic process(GO:0006221) |
0.1 | 7.9 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.1 | 0.3 | GO:0060005 | vestibular reflex(GO:0060005) |
0.1 | 0.4 | GO:0002329 | pre-B cell differentiation(GO:0002329) pre-B cell allelic exclusion(GO:0002331) |
0.1 | 0.4 | GO:1902938 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
0.1 | 0.3 | GO:0045556 | TRAIL biosynthetic process(GO:0045553) regulation of TRAIL biosynthetic process(GO:0045554) positive regulation of TRAIL biosynthetic process(GO:0045556) |
0.1 | 2.5 | GO:1901685 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
0.1 | 0.9 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.1 | 0.8 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.1 | 0.5 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.1 | 0.2 | GO:1990535 | neuron projection maintenance(GO:1990535) |
0.1 | 1.1 | GO:0045794 | negative regulation of cell volume(GO:0045794) |
0.1 | 1.9 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.1 | 0.5 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.1 | 0.5 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.1 | 3.4 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.1 | 0.3 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.1 | 1.9 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.1 | 0.9 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.1 | 1.1 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
0.1 | 1.3 | GO:0072540 | natural killer cell proliferation(GO:0001787) T-helper 17 cell lineage commitment(GO:0072540) |
0.1 | 0.2 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.1 | 0.6 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
0.1 | 2.2 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 0.7 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.1 | 0.6 | GO:0071503 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
0.1 | 1.0 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
0.1 | 1.7 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.1 | 0.9 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
0.1 | 0.3 | GO:0009753 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
0.1 | 0.5 | GO:0061205 | alveolar primary septum development(GO:0061143) paramesonephric duct development(GO:0061205) |
0.1 | 0.2 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.1 | 0.4 | GO:2001205 | negative regulation of osteoclast development(GO:2001205) |
0.1 | 0.2 | GO:0051039 | histone displacement(GO:0001207) positive regulation of transcription involved in meiotic cell cycle(GO:0051039) |
0.1 | 0.6 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.1 | 3.6 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.1 | 6.8 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.1 | 2.7 | GO:0097484 | dendrite extension(GO:0097484) |
0.1 | 1.3 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.1 | 0.6 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.1 | 1.1 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.1 | 0.3 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.1 | 0.2 | GO:0035425 | autocrine signaling(GO:0035425) canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.1 | 0.5 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.1 | 0.2 | GO:2000364 | cardiac muscle tissue regeneration(GO:0061026) regulation of STAT protein import into nucleus(GO:2000364) positive regulation of STAT protein import into nucleus(GO:2000366) |
0.1 | 0.5 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
0.1 | 3.1 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.1 | 1.5 | GO:2000757 | negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.1 | 0.4 | GO:0008050 | negative regulation of female receptivity(GO:0007621) female courtship behavior(GO:0008050) |
0.1 | 0.6 | GO:0036155 | acylglycerol acyl-chain remodeling(GO:0036155) |
0.1 | 2.0 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.1 | 1.4 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.1 | 0.7 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.1 | 3.8 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.1 | 0.3 | GO:0006548 | histamine metabolic process(GO:0001692) histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.1 | 2.3 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.1 | 0.4 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.0 | 0.4 | GO:0086043 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.0 | 0.5 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.0 | 1.2 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
0.0 | 0.8 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.0 | 0.3 | GO:0015705 | iodide transport(GO:0015705) |
0.0 | 0.4 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.0 | 1.3 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.0 | 0.2 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) |
0.0 | 0.7 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.0 | 0.6 | GO:0032096 | negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
0.0 | 0.3 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 1.3 | GO:0097502 | mannosylation(GO:0097502) |
0.0 | 7.1 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.5 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.0 | 0.3 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.0 | 0.8 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.0 | 0.3 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.0 | 0.9 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.0 | 0.3 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
0.0 | 0.9 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.3 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.0 | 1.2 | GO:0015695 | organic cation transport(GO:0015695) |
0.0 | 0.5 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.0 | 0.4 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.0 | 0.4 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) arterial endothelial cell differentiation(GO:0060842) |
0.0 | 0.3 | GO:0070202 | regulation of establishment of protein localization to chromosome(GO:0070202) |
0.0 | 0.6 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.0 | 0.3 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.0 | 0.4 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.0 | 1.2 | GO:0048665 | neuron fate specification(GO:0048665) |
0.0 | 0.2 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.0 | 0.9 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.0 | 1.0 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.0 | 0.4 | GO:0006983 | ER overload response(GO:0006983) |
0.0 | 1.0 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.0 | 0.4 | GO:0003334 | keratinocyte development(GO:0003334) |
0.0 | 0.5 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.0 | 1.7 | GO:1901222 | regulation of NIK/NF-kappaB signaling(GO:1901222) |
0.0 | 0.2 | GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
0.0 | 1.1 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.0 | 1.0 | GO:0097435 | fibril organization(GO:0097435) |
0.0 | 0.6 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
0.0 | 2.2 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
0.0 | 1.3 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.0 | 0.7 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
0.0 | 0.6 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.0 | 0.7 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
0.0 | 1.1 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
0.0 | 1.0 | GO:0003254 | regulation of membrane depolarization(GO:0003254) |
0.0 | 1.1 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.0 | 0.4 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.0 | 0.3 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.0 | 0.8 | GO:0035640 | exploration behavior(GO:0035640) |
0.0 | 0.5 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
0.0 | 0.2 | GO:0015816 | glycine transport(GO:0015816) |
0.0 | 0.2 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.0 | 0.7 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.0 | 0.4 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.0 | 0.4 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.0 | 0.1 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.0 | 0.4 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
0.0 | 0.4 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.0 | 0.1 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.0 | 0.7 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.0 | 0.1 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.0 | 0.3 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.0 | 0.1 | GO:0070857 | regulation of bile acid biosynthetic process(GO:0070857) |
0.0 | 0.1 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.0 | 0.7 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.0 | 0.6 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.0 | 1.3 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.0 | 1.5 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
0.0 | 0.9 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.0 | 1.1 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.0 | 0.8 | GO:0061178 | regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061178) |
0.0 | 0.2 | GO:0009642 | response to light intensity(GO:0009642) |
0.0 | 1.1 | GO:0007032 | endosome organization(GO:0007032) |
0.0 | 0.2 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.0 | 0.1 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.0 | 0.1 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.0 | 0.9 | GO:0001895 | retina homeostasis(GO:0001895) |
0.0 | 0.1 | GO:0006069 | ethanol oxidation(GO:0006069) |
0.0 | 0.1 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.0 | 1.1 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
0.0 | 0.5 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.2 | GO:1900115 | extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.0 | 0.7 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
0.0 | 0.2 | GO:0034389 | lipid particle organization(GO:0034389) |
0.0 | 0.2 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.0 | 0.5 | GO:0048747 | muscle fiber development(GO:0048747) |
0.0 | 0.3 | GO:0006692 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.0 | 1.2 | GO:1990823 | response to leukemia inhibitory factor(GO:1990823) cellular response to leukemia inhibitory factor(GO:1990830) |
0.0 | 0.3 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.0 | 0.5 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.0 | 0.4 | GO:0019228 | neuronal action potential(GO:0019228) |
0.0 | 0.8 | GO:0048207 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.0 | 0.5 | GO:0016079 | synaptic vesicle exocytosis(GO:0016079) |
0.0 | 0.7 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 25.8 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
1.2 | 3.7 | GO:0097441 | basilar dendrite(GO:0097441) |
0.8 | 4.0 | GO:0031673 | H zone(GO:0031673) |
0.6 | 4.4 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.5 | 6.6 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.5 | 3.8 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.5 | 2.8 | GO:0060203 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
0.5 | 1.9 | GO:0070876 | SOSS complex(GO:0070876) |
0.4 | 2.4 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.4 | 1.5 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.4 | 1.2 | GO:0097181 | protein C inhibitor-TMPRSS7 complex(GO:0036024) protein C inhibitor-TMPRSS11E complex(GO:0036025) protein C inhibitor-PLAT complex(GO:0036026) protein C inhibitor-PLAU complex(GO:0036027) protein C inhibitor-thrombin complex(GO:0036028) protein C inhibitor-KLK3 complex(GO:0036029) protein C inhibitor-plasma kallikrein complex(GO:0036030) serine protease inhibitor complex(GO:0097180) protein C inhibitor-coagulation factor V complex(GO:0097181) protein C inhibitor-coagulation factor Xa complex(GO:0097182) protein C inhibitor-coagulation factor XI complex(GO:0097183) |
0.4 | 9.4 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.4 | 2.2 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.3 | 4.4 | GO:0031209 | SCAR complex(GO:0031209) |
0.3 | 1.0 | GO:0098536 | deuterosome(GO:0098536) |
0.3 | 3.0 | GO:0005614 | interstitial matrix(GO:0005614) |
0.3 | 1.8 | GO:0033063 | DNA recombinase mediator complex(GO:0033061) Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.3 | 4.4 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.3 | 1.6 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
0.3 | 3.9 | GO:0030478 | actin cap(GO:0030478) |
0.3 | 3.5 | GO:0005642 | annulate lamellae(GO:0005642) |
0.2 | 4.2 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.2 | 0.7 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.2 | 2.8 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.2 | 0.7 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.2 | 4.1 | GO:0032982 | myosin filament(GO:0032982) |
0.2 | 2.7 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.2 | 1.2 | GO:0071797 | LUBAC complex(GO:0071797) |
0.2 | 0.6 | GO:0034455 | t-UTP complex(GO:0034455) |
0.2 | 10.0 | GO:0031430 | M band(GO:0031430) |
0.2 | 0.9 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
0.2 | 0.7 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.2 | 6.3 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.2 | 1.1 | GO:0043196 | varicosity(GO:0043196) |
0.2 | 0.5 | GO:0055087 | Ski complex(GO:0055087) |
0.2 | 0.9 | GO:0005818 | astral microtubule(GO:0000235) aster(GO:0005818) |
0.1 | 2.5 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.1 | 2.2 | GO:0034709 | methylosome(GO:0034709) |
0.1 | 3.9 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 1.6 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.1 | 1.8 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.1 | 0.5 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 7.4 | GO:0005871 | kinesin complex(GO:0005871) |
0.1 | 5.6 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 2.3 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.1 | 1.5 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.1 | 1.2 | GO:0016013 | syntrophin complex(GO:0016013) |
0.1 | 0.3 | GO:0032426 | stereocilium tip(GO:0032426) |
0.1 | 0.6 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
0.1 | 0.5 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.1 | 1.9 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.1 | 0.6 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.1 | 0.3 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 4.1 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.1 | 2.5 | GO:0005902 | microvillus(GO:0005902) |
0.1 | 1.0 | GO:0043083 | synaptic cleft(GO:0043083) |
0.1 | 0.7 | GO:0098644 | complex of collagen trimers(GO:0098644) |
0.1 | 3.4 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 11.3 | GO:0030018 | Z disc(GO:0030018) |
0.1 | 0.2 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.1 | 0.8 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 0.7 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 2.2 | GO:0043218 | compact myelin(GO:0043218) |
0.1 | 1.6 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.1 | 0.8 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 11.5 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.1 | 1.0 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 1.8 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.1 | 0.8 | GO:0097433 | dense body(GO:0097433) |
0.1 | 1.4 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.0 | 0.3 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) synaptobrevin 2-SNAP-25-syntaxin-3-complexin complex(GO:0070554) |
0.0 | 0.9 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 0.8 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.0 | 0.7 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.0 | 1.3 | GO:0035267 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.0 | 0.3 | GO:0034706 | sodium channel complex(GO:0034706) |
0.0 | 0.1 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
0.0 | 0.7 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.0 | 0.4 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.0 | 0.4 | GO:0070449 | elongin complex(GO:0070449) |
0.0 | 2.2 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.6 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.0 | 0.7 | GO:0036038 | MKS complex(GO:0036038) |
0.0 | 0.1 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.0 | 0.5 | GO:0019774 | proteasome core complex, beta-subunit complex(GO:0019774) |
0.0 | 2.9 | GO:0005643 | nuclear pore(GO:0005643) |
0.0 | 0.4 | GO:0043194 | axon initial segment(GO:0043194) |
0.0 | 2.4 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 0.3 | GO:0033202 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
0.0 | 0.5 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 0.7 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.0 | 4.6 | GO:0043204 | perikaryon(GO:0043204) |
0.0 | 4.7 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.6 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.0 | 1.3 | GO:0098576 | lumenal side of membrane(GO:0098576) |
0.0 | 1.5 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 9.1 | GO:0031965 | nuclear membrane(GO:0031965) |
0.0 | 0.8 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.0 | 0.2 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.0 | 0.8 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.0 | 1.2 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.0 | 0.5 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.0 | 0.1 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.0 | 2.0 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 0.3 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.0 | 1.2 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 6.4 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 1.8 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 2.4 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.0 | 0.2 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.0 | 0.2 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.0 | 1.1 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.0 | 0.2 | GO:0030686 | 90S preribosome(GO:0030686) |
0.0 | 0.2 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.0 | 2.2 | GO:0043209 | myelin sheath(GO:0043209) |
0.0 | 2.0 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) potassium channel complex(GO:0034705) |
0.0 | 0.2 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.0 | 1.4 | GO:0005875 | microtubule associated complex(GO:0005875) |
0.0 | 0.3 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 0.1 | GO:0097427 | microtubule bundle(GO:0097427) |
0.0 | 0.5 | GO:0071564 | SWI/SNF complex(GO:0016514) npBAF complex(GO:0071564) |
0.0 | 0.4 | GO:0032040 | small-subunit processome(GO:0032040) |
0.0 | 0.3 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 1.4 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.0 | 0.3 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.0 | 0.7 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.0 | 0.7 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.0 | 3.5 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.0 | 1.5 | GO:0030426 | growth cone(GO:0030426) |
0.0 | 1.7 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.0 | 1.0 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 1.3 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 0.0 | GO:0048179 | activin receptor complex(GO:0048179) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.4 | 13.7 | GO:1904408 | dihydronicotinamide riboside quinone reductase activity(GO:0001512) melatonin binding(GO:1904408) |
0.9 | 6.3 | GO:0102344 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.8 | 4.1 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.8 | 2.5 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.7 | 4.5 | GO:0016807 | cysteine-type carboxypeptidase activity(GO:0016807) cysteine-type exopeptidase activity(GO:0070004) |
0.7 | 6.0 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
0.7 | 2.0 | GO:0030337 | DNA polymerase processivity factor activity(GO:0030337) |
0.7 | 3.9 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.7 | 9.8 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.6 | 4.4 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.6 | 1.8 | GO:0045550 | geranylgeranyl reductase activity(GO:0045550) delta4-3-oxosteroid 5beta-reductase activity(GO:0047787) |
0.6 | 2.8 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.5 | 1.6 | GO:0004766 | spermidine synthase activity(GO:0004766) |
0.5 | 2.9 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.5 | 2.4 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
0.4 | 1.3 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
0.4 | 1.2 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.4 | 1.6 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.4 | 1.5 | GO:0033823 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
0.4 | 2.7 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.3 | 1.4 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.3 | 2.4 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.3 | 3.0 | GO:0045545 | syndecan binding(GO:0045545) |
0.3 | 8.8 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.3 | 3.7 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.3 | 26.7 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.3 | 3.6 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.3 | 1.8 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.3 | 9.3 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.3 | 7.9 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.3 | 2.2 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.3 | 0.8 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.3 | 4.0 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.3 | 1.0 | GO:0001626 | nociceptin receptor activity(GO:0001626) |
0.3 | 0.8 | GO:0033858 | N-acetylgalactosamine kinase activity(GO:0033858) |
0.3 | 5.0 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.2 | 1.5 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.2 | 2.7 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.2 | 2.6 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.2 | 0.7 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.2 | 1.4 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.2 | 1.6 | GO:0031013 | troponin I binding(GO:0031013) |
0.2 | 0.9 | GO:0004504 | peptidylglycine monooxygenase activity(GO:0004504) peptidylamidoglycolate lyase activity(GO:0004598) |
0.2 | 2.3 | GO:1990948 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
0.2 | 2.0 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.2 | 8.4 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.2 | 2.4 | GO:0004568 | chitinase activity(GO:0004568) chitin binding(GO:0008061) |
0.2 | 0.9 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
0.2 | 5.1 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.2 | 1.2 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.2 | 1.9 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.2 | 1.2 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.2 | 10.6 | GO:0030507 | spectrin binding(GO:0030507) |
0.2 | 0.8 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
0.2 | 1.5 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.2 | 0.8 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
0.2 | 4.3 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.2 | 3.3 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
0.2 | 11.2 | GO:0015485 | cholesterol binding(GO:0015485) |
0.2 | 0.9 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.2 | 1.8 | GO:0004064 | arylesterase activity(GO:0004064) |
0.2 | 0.7 | GO:0098770 | FBXO family protein binding(GO:0098770) |
0.2 | 1.4 | GO:0050694 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
0.2 | 0.5 | GO:0015403 | thiamine transmembrane transporter activity(GO:0015234) thiamine uptake transmembrane transporter activity(GO:0015403) |
0.2 | 0.5 | GO:0001596 | angiotensin type I receptor activity(GO:0001596) |
0.2 | 2.0 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.2 | 3.4 | GO:0031005 | filamin binding(GO:0031005) |
0.2 | 0.5 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
0.2 | 4.9 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.2 | 1.1 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.2 | 2.3 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.2 | 2.8 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.2 | 0.3 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.1 | 4.9 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 0.4 | GO:0080130 | L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.1 | 0.9 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.1 | 2.8 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.1 | 4.2 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 1.0 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.1 | 0.7 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.1 | 0.5 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
0.1 | 0.3 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.1 | 0.6 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 2.3 | GO:0030957 | Tat protein binding(GO:0030957) |
0.1 | 1.1 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
0.1 | 0.9 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.1 | 2.9 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 0.5 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 1.3 | GO:0008556 | potassium-transporting ATPase activity(GO:0008556) |
0.1 | 0.4 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.1 | 0.4 | GO:0004958 | prostaglandin F receptor activity(GO:0004958) |
0.1 | 1.2 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 1.4 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
0.1 | 0.5 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.1 | 0.7 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.1 | 1.3 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.1 | 0.9 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
0.1 | 0.7 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
0.1 | 2.2 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 0.3 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
0.1 | 0.4 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.1 | 2.9 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.3 | GO:0001641 | group II metabotropic glutamate receptor activity(GO:0001641) |
0.1 | 1.8 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 0.4 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.1 | 1.6 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.1 | 5.6 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.1 | 0.4 | GO:0001132 | RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly(GO:0001129) RNA polymerase II transcription factor activity, TBP-class protein binding(GO:0001132) |
0.1 | 8.8 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 0.3 | GO:0016524 | latrotoxin receptor activity(GO:0016524) |
0.1 | 0.5 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.1 | 2.9 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.1 | 0.7 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.1 | 0.7 | GO:0089720 | caspase binding(GO:0089720) |
0.1 | 1.2 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.1 | 0.5 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.1 | 1.5 | GO:0030506 | ankyrin binding(GO:0030506) |
0.1 | 2.7 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.1 | 0.8 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.1 | 1.8 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 2.2 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 0.3 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.1 | 0.9 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.1 | 1.2 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.1 | 6.8 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.1 | 0.6 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.1 | 0.4 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.1 | 3.1 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.1 | 0.4 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.1 | 1.9 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.1 | 3.1 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.1 | 0.6 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.1 | 0.5 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.1 | 11.4 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.1 | 2.0 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.1 | 0.3 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.1 | 0.8 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.1 | 0.5 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.1 | 0.7 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.1 | 0.3 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.1 | 0.3 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.1 | 0.9 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.1 | 0.6 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.1 | 0.6 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 1.0 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.1 | 0.5 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.1 | 0.3 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.1 | 0.3 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.1 | 1.3 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.1 | 0.9 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.1 | 1.3 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.0 | 0.3 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.0 | 0.2 | GO:0019862 | IgA binding(GO:0019862) |
0.0 | 1.3 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.0 | 0.5 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.0 | 0.4 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.0 | 0.4 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
0.0 | 0.9 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.0 | 0.6 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 0.7 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.8 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.5 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.0 | 0.5 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.3 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.0 | 0.2 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.0 | 0.0 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.0 | 0.9 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.0 | 1.1 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.0 | 3.1 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.0 | 0.5 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 1.2 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 3.6 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 4.8 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.0 | 1.1 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.0 | 1.9 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 1.4 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.0 | 0.2 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.0 | 1.1 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.8 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.0 | 0.2 | GO:1903763 | gap junction channel activity involved in cell communication by electrical coupling(GO:1903763) |
0.0 | 0.2 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.0 | 0.3 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
0.0 | 0.7 | GO:0016875 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.0 | 0.3 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.0 | 0.7 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.0 | 0.4 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.0 | 6.3 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 1.3 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 0.8 | GO:0071949 | FAD binding(GO:0071949) |
0.0 | 0.2 | GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
0.0 | 1.3 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 0.4 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.0 | 0.4 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.6 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.0 | 0.2 | GO:0098960 | postsynaptic neurotransmitter receptor activity(GO:0098960) |
0.0 | 0.8 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.0 | 0.3 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.0 | 0.1 | GO:0003998 | acylphosphatase activity(GO:0003998) |
0.0 | 0.8 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 0.6 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.3 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.0 | 1.1 | GO:0001099 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.0 | 0.5 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.0 | 1.1 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.0 | 2.4 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 7.4 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.0 | 0.3 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 1.5 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.0 | 0.2 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 1.0 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 0.5 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.0 | 0.5 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 1.7 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.0 | 0.7 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.0 | 0.3 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.0 | 2.3 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 0.3 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 1.7 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 1.0 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.0 | 0.3 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.0 | 0.1 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.0 | 0.1 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.0 | 0.1 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.0 | 0.7 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.5 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.0 | 0.4 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.0 | 0.2 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.0 | 0.4 | GO:0000217 | DNA secondary structure binding(GO:0000217) |
0.0 | 0.8 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.7 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.0 | 0.1 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.0 | 0.7 | GO:0015179 | L-amino acid transmembrane transporter activity(GO:0015179) |
0.0 | 0.6 | GO:0003684 | damaged DNA binding(GO:0003684) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 25.8 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.3 | 3.4 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.2 | 6.7 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.2 | 2.6 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.2 | 2.9 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 6.4 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 2.7 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 2.9 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 7.4 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 0.5 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 1.6 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 4.9 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 2.9 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 4.7 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 3.4 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 4.7 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 3.8 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 0.6 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.1 | 1.6 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 2.0 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 1.3 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 1.0 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 2.1 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 3.2 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.0 | 0.9 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 0.9 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 2.2 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.8 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 1.0 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.6 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 0.8 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.0 | 2.0 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.7 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 1.5 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 1.4 | PID PLK1 PATHWAY | PLK1 signaling events |
0.0 | 1.5 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 1.0 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 4.6 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.0 | 0.7 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 1.1 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.6 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 3.5 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.7 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.0 | 2.0 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 0.9 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.9 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 4.7 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.2 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.7 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.6 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 1.3 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.5 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 0.3 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 25.6 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.3 | 8.2 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.3 | 10.6 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.3 | 8.6 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.3 | 4.6 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.3 | 7.3 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.3 | 5.0 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.3 | 7.4 | REACTOME KINESINS | Genes involved in Kinesins |
0.3 | 0.8 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.2 | 2.5 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.2 | 5.4 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.2 | 3.9 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.2 | 11.9 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.2 | 2.9 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.2 | 3.9 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
0.2 | 1.5 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.2 | 1.7 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.1 | 8.4 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 1.5 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.1 | 2.0 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.1 | 4.3 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.1 | 2.1 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.1 | 1.4 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.1 | 1.8 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.1 | 3.3 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 0.7 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.1 | 1.6 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 1.5 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.1 | 3.5 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.1 | 3.3 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.1 | 1.7 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.1 | 0.9 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.1 | 1.6 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.1 | 4.3 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.1 | 5.9 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.1 | 0.7 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 3.0 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.1 | 1.1 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.1 | 1.4 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 2.1 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 0.3 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.1 | 1.0 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 2.3 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 2.0 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 4.7 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 1.5 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 1.0 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.0 | 1.9 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 1.6 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.7 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.0 | 1.2 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 1.8 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 1.3 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.9 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.0 | 2.3 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.0 | 4.1 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 0.8 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 0.4 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.4 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.2 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.0 | 1.1 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.0 | 0.5 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.3 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.0 | 1.7 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.7 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.3 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 0.5 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.0 | 3.0 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.0 | 0.3 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.0 | 1.3 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 0.3 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 1.0 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.4 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 0.4 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.0 | 0.4 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.0 | 0.1 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 0.3 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |